Abstract
Deprescribing refers to reducing or stopping medications that may no longer be needed, may be causing more harm than good, or may not align with a patient’s healthcare goals and treatment preferences. This chapter provides a historical perspective on the problem of too much medication among older persons, describes practice and research initiatives in the field over the last two decades, and outlines healthcare provider education, public engagement approaches, and policy strategies that have been used to promote deprescribing. Each section concludes with recommendations for future work. The chapter uses a narrative approach and shares how we, as authors, have been involved in some of the initiatives by sharing some examples from our work.
This is a preview of subscription content, log in via an institution to check access.
References
Ailabouni NJ, et al. Leveraging implementation science to increase the translation of deprescribing evidence into practice. Res Social Adm Pharm. 2021;S1551-7411(21):00184. https://doi.org/10.1016/j.sapharm.2021.05.018.
Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimizing potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014a;4:e006544. https://doi.org/10.1136/bmjopen-2014-006544.
Aubert CE, Kerr EA, Maratt JK, et al. Outcome measures for interventions to reduce inappropriate chronic drugs: a narrative review. J Am Geriatr Soc. 2020;68:2390–8.
Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56:1946–52.
Beard K. Adverse reactions as a cause of hospital admission in the aged. Drugs Aging. 1992;2(4):356–67. https://doi.org/10.2165/00002512-199202040-00008.
Beer C, et al. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2(2):37–43. https://doi.org/10.1177/2042098611400332.
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825–32.
Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging. 1999;14(3):231–9. https://doi.org/10.2165/00002512-199914030-00005.
Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V, Wiens A. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia (BPSD) and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17–27.
Bloomfield HE, Greer N, Linsky AM, Bolduc J, Naidl T, Vardeny O, MacDonald R, McKenzie L, Wilt TJ. Deprescribing for community-dwelling older adults: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(11):3323–32. https://doi.org/10.1007/s11606-020-06089-2.
Burghle A, et al. Attitudes towards Deprescribing among older adults with limited life expectancy and their relatives: a systematic review. Drugs Aging. 2020;37(7):503–20. https://doi.org/10.1007/s40266-020-00774-x.
Cassels A. "can I stop even one of these pills?" the development of a tool to make deprescribing easier. Eur J Hosp Pharm. 2017;24(1):3–4.
Christensen M, et al. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2 https://doi.org/10.1002/14651858.CD008986.pub3.
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. McGraw-hill, Health Professions Division. University of Michigan; 1998a.
Cochrane 2012. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008165.pub2/abstract
Cohen JS. Avoiding adverse drug reactions. Effective lower-dose drug therapies for older patients. Geriatrics. 2000;55(2):63–4.
Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med. 1993;8(50):278–83. https://doi.org/10.1007/BF02600099.
Conklin J, Farrell B, Suleman S. Implementing deprescribing guidelines into frontline practice: barriers and facilitators. Res Soc Adm Pharm. 2019;15(6):796–800. https://www.sciencedirect.com/science/article/pii/S1551741118307526)
Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, Hughes CM. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5(12):e009235. https://doi.org/10.1136/bmjopen-2015-009235.
Curran HV, Collins R, Fletcher S, et al. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med. 2003;33:1223–37.
Curtin D, et al. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019;13(10):2042098619829431. https://doi.org/10.1177/2042098619829431. eCollection 2019
Dills H, Shah K, Messinger-Rapport B, Bradford K, Syed Q. Deprescribing medications for chronic disease management in primary care settings: a systematic review of randomized controlled trials. J Am Med Dir Assoc. 2018;19(11):923–935.e2. https://doi.org/10.1016/j.jamda.2018.06.021.
Doherty A, et al. Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open. 2020;4(3) https://doi.org/10.3399/bjgpopen20X101096. Print 2020 Aug
Dolovich L, Pottie K, Kaczorowski J, Farrell B, Austin Z, Rodriquez C, Gaebel K, Sellors C. Integrating family medicine and pharmacy to advance primary care therapeutics: a collaborative practice model between physicians and pharmacists. Clin Pharmacol Ther. 2008;83(6):913–7.
Eriksen SI, Bjerrum L. Reducing prescriptions of long-acting benzodizepine drugs in Denmark: a descriptive analysis of nationwide prescriptions during a 10-year period. Basic Clin Pharmacol Toxicol 2015;116(6):499–502. https://pubmed.ncbi.nlm.nih.gov/25382355/
Fajardo MA, Weir KR, Bonner C, Gnjidic D, Jansen J. Availability and readability of patient education materials for deprescribing: an environmental scan. Br J Clin Pharmacol. 2019a:bcp.13912.
Farrell B, Babcock K, Hughes L. Facilitating the process of medication re-evaluation and withdrawal in the long-term institutionalized population. Example: cisapride. Can J Hosp Pharm. 2003;56:32–40.
Farrell B, Pottie K, Hogg W. Adverse drug reactions in unrecognized kidney failure: the case of an elderly patient. Can Fam Phys. 2004;50:1385–7.
Farrell B, Pora V, Babcock K. Stopping medications in complex continuing care: the example of baclofen and dantrolene. Can J Hosp Pharm. 2006;59:264–72.
Farrell B, Shamji S, Monahan A, French MV. Clinical vignettes to help you deprescribe medications in elderly patients: introduction to the polypharmacy case series. Can Fam Physician. 2013a;59:1257–8.
Farrell B, Shamji S, Monahan A, French MV. Reducing polypharmacy in the elderly: cases to help you rock the boat. Can Pharm J. 2013b;146(5):243–4.
Farrell B, French Merkley V, Ingar N. Reducing pill burden and helping with medication awareness to improve adherence. Can Pharm J. 2013c;146(5):262–9.
Farrell B, Merkley F, Thompson W. Managing polypharmacy in a 77-year-old woman with multiple prescribers. CMAJ. 2013d;185:1240–5.
Farrell B, Shamji S, Ingar N. Reducing fall risk while managing hypotension, pain and poor sleep in an 83 year old woman. Can Fam Physician. 2013e;59:1300–5.
Farrell B, Shamji S, Ingar N. Reducing fall risk while managing pain and insomnia: addressing polypharmacy in an 81 year old woman. Can Pharm J. 2013f;146(6):335–41.
Farrell B, Eisener-Parsche P, Dalton D. Turning over the rocks – the role of anticholinergics and benzodiazepines in cognitive decline and falls. Can Fam Physician. 2014a;60:345–50.
Farrell B, Monahan A, Thompson W. Revisiting ongoing medication use in a frail 93 year old experiencing possible adverse effects. Can Med Assoc J. 2014b;186:445–9. https://doi.org/10.1503/cmaj.130523.
Farrell B, Shamji S, Dalton D. Managing chronic disease in the frail elderly – more than just adhering to clinical guidelines. Can Pharm J. 2014c;147(2):89–96.
Farrell B, Monahan A, Ingar N. Identifying and managing drug-related causes of common geriatric symptoms. Can Fam Physician. 2014d;60:147–53.
Farrell B, Pottie K, Rojas-Fernandez C, Bjerre LM, Thompson W, Welch V. Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. PLoS One. 2016;11(8):e0161248. https://doi.org/10.1371/journal.pone.0161248. eCollection.
Farrell B, Black C, Thompson W, McCarthy L, Rojas-Fernandez C, Lochnan H, Shamji S, Upshur R, Bouchard M, Welch V. Deprescribing antihyperglycemic agents in older persons: an evidence-based clinical practiced guideline. Can Fam Physician. 2017a;63(11):832–42.
Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, Rojas-Fernandez C, Walsh K, Welch V, Moayyedi P. Deprescribing proton-pump inhibitors: an evidence based clinical practice guideline. Can Fam Physician. 2017b;63(5):354–64.
Farrell B, Richardson L, Raman-Wilms L, de Launay D, Alsabbagh MW, Conklin J. Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines. Res Soc Adm Pharm. 2018a;14(1):18–25.
Farrell B, Grad R, Howell P, Quast T, Reeve E. Deprescribing guidelines: value of an interactive mobile application. PRiMER. 2020a;4:26.
Frank C. Deprescribing: a new word to guide medication review. CMAJ. 2014;186(6):407–8.
Frank C, Weir E. Deprescribing for older patients. CMAJ. 2014;186(18):1369–76.
Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123–32. https://doi.org/10.1111/j.1041-2972.2005.0020.x.
Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older Person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008a;46:72–83.
Galley E, Farrell B, Conklin J, Howell P, McCarthy LM, Raman-Wilms L. Using community engagement to initiate conversations about deprescribing in primary care. J Commun Engage Scholar. (under review, 2021).
Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9:430–4.
Gnjidic D, Le Couter DG, Kouladijan L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237–53. https://doi.org/10.1016/j.cger.2012.01.006. Epub 2012 Feb 21.
Goldber PB, Roberts J. Pharmacologic basis for developing rational drug regimens for elderly patients. Med Clin North Am. 1983;67(2):315–31. https://doi.org/10.1016/s0025-7125(16)31206-8.
Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med. 1997;157:2205–10.
Habraken H, Soenen K, Blondeel L, et al. Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research. Eur J Clin Pharmacol. 1997;51:355–8.
Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51. https://doi.org/10.1016/j.amjopharm.2007.12.002.
Hanlon JT, Schmader KE. The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013;30:893–900.
Hansen CR, O'Mahony D, Kearney PM, Sahm LJ, Cullinan S, Huibers CJA, Thevelin S, Rutjes AWS, Knol W, Streit S, Byrne S. Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysis. Br J Clin Pharmacol. 2018a;84(12):2716–28. https://doi.org/10.1111/bcp.13742.
Hardy JE, Hilmer SN. Deprescribing in the last year of life. J Pharm Pract Res. 2011;41:146–51.
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990a;47(3):533–43.
Hilmer SN, Gnjidic D, Le Couteur DG. Thinking through the medication list. Appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician. 2012;41(12):924–8.
Institute for Healthcare Improvement, Reducing Inappropriate Medication Use by Implementing Deprescribing Guidelines | IHI - Institute for Healthcare Improvement (needs to be properly formatted as citation).
Isenor E, Bai I, Cormier R, Jhelwig M, Reeve E, Whelan AM, Burgess S, Martin-Misener R, Kennie-Kaulbach N. Deprescribing interventions in primary health care mapped to the behaviour change wheel: a scoping review. RSAP. 2021a;17(7):1229–41.
Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 and older: a systematic review. Drugs Aging. 2008;25:1021–31.
Jansen J, Naganathan V, Carter SM, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;353:i2893. https://doi.org/10.1136/bmj.i2893.
Johansson T, Abuzahra ME, Keller S, Mann E, Faller B, Sommerauer C, Hock J, Loffler C, Kochling A, Schuler J, Flamm M, Sonnichsen A. Impact of strategies to reduce polypharmacy on clinical endpoints: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(8):532–48. https://doi.org/10.1111/bcp.12959. Epub 2016 May 7
Kwan D, Farrell B. Polypharmacy: Optimizing medication use in elderly patients. Pharm Pract. 2013:20–5.
Lavan A, Gallagher P, Parsons C, et al. STOPPFrail (screening tool of older persons prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2016;45:1–12.
Le Couteur DG, Hilmer SN, Glasgow N, Naganathan V, Cumming RG. Prescribing in older people. Aust Fam Physician. 2004;33(10):777–81.
Lemay G, Daziel B. Better prescribing in the elderly. Can Geriatrics Soc J CME. 2012;2(3):20–6.
Lin Chock YL, et al. How willing are patients or their caregivers to Deprescribe: a systematic review and meta-analysis. J Gen Intern Med. 2021;36 https://doi.org/10.1007/s11606-021-06965-5. Online ahead of print
Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc. 2002;42(6):847–57. https://doi.org/10.1331/108658002762063682.
Lundby C, et al. Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: a systematic review. Br J Clin Pharmacol. 2019;85(5):868–92. https://doi.org/10.1111/bcp.13861. Epub 2019 Feb 27
Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. JAMA. 2018;320(18):1889–98. https://doi.org/10.1001/jama.2018.16131.
Masnoon. Tools for assessment of the appropriateness of prescribing and association with patient-related outcomes: a systematic review. Drugs Aging. 2018;35(1):43–60. https://doi.org/10.1007/s40266-018-0516-8.
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230.
McKellar GD, Hampson R, Tierney A, et al. Nonsteroidal antiinflammatory drug withdrawal in patients with stable rheumatoid arthritis. J Rheumatol. 2011a;38:2150–2.
McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156:385–91.
Meador KJ. Cognitive side effects of medications. Neurol Clin. 1998;16(1):141–55. https://doi.org/10.1016/s0733-8619(05)70371-7.
Michiels-Corsten M, et al. Generic instruments for drug discontinuation in primary care: A systematic review. Br J Clin Pharmacol. 2020;86(7):1251–66. https://doi.org/10.1111/bcp.14287. Epub 2020 Apr 5
Monteiro L, et al. Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review. J Med Internet Res. 2019;21(11):e15385. https://doi.org/10.2196/15385.
O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37(2):138–41. https://doi.org/10.1093/ageing/afm189.
O’Mahony, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.
Page AT, et al. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(3):583–623. https://doi.org/10.1111/bcp.12975. Epub 2016 Jun 13
Paque K, et al. Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med. 2019;33(1):37–48.
Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012;5. Art. No.: CD008165. https://doi.org/10.1002/14651858.CD008165.pub2
Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B. Deprescribing benzodiazepine receptor agonists: evidence based clinical practice guideline. Can Fam Physician. 2018;64:339–51.
Pruskoswki JA, Springer S, Thorpe CT, Klein-Fedyshin M, Handler SM. Does deprescribing improve quality of life? A systematic review of the literature. Drugs Aging. 2019;36(12):1097–110. https://doi.org/10.1007/s40266-019-00717-1en20X101096.
Queneau P. Treatment is also a science and the art of deprescribing. Presse Med. 2004;33(9 Pt 1):583–5. https://doi.org/10.1016/20755-4982(04)98680-0.
Queneau P, Doucet J, Paille F. When deprescribing drugs can improve the elderly patient's health. Bull Acad Natl Med. 2007;191(2):271–82. discussion 282–5
Rankin A, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9(9):CD008165. https://doi.org/10.1002/14651858.CD008165.pub4.
Reeve E. Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice. J Pharm Pract Res. 2020;50 https://doi.org/10.1002/jppr.1626.
Reeve E, To E, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.
Reeve E, Shakib S, Hendrix I, et al. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014a;78:738–47.
Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eu J Int Med. 2017;28:3–11.
Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin P, Chenoweth L, Gorman M, Quirke L, Bethune G, Forbes F, Hilmer S. Evidence-based clinical practice guideline for Deprescribing cholinesterase inhibitors and Memantine. Sydney: University of Sydney; 2018. Available at: http://sydney.edu.au/medicine/cdpc/resources/deprescribing-guidelines.php
Rodríguez-Pérez A, Alfaro-Lara ER, Albiñana-Perez S, et al. Novel tool for deprescribing in chronic patients with multimorbidity: list of evidence-based deprescribing for chronic patients criteria. Geriatr Gerontol Int. 2017;17:2200–7.
Sawan M, et al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020a;13(3):233–45. https://doi.org/10.1080/17512433.2020.1730812.
Schmucker DL, Vesell ES. Are the elderly underrepresented in clinical drug trials? J Clin Pharmacol. 1999;39(11):1103–8.
Scott IA, Gray LC, Martin JH, Pillans PI, Mitchell CA. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med. 2013;18(4):121–4.
Scott IA, et al. First do no harm: a real need to deprescribe in older patients. Med J Aust. 2014;201(7):390–2. https://doi.org/10.5694/mja14.00146.
Scott I, Hilmer S, Reeve S, Potter K, Le Couteur D, Rigby D, Gnjidic D, del Mar C, Roughead E, Page A, Jansen J, Martin J. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.
Sloan RW. Principles of drug therapy in geriatric patients. Am Fam Phys. 1992;45(6):2709–18.
Stewart RB, Cooper JW. Polypharmacy in the aged. Pract Sol Drugs Aging. 1994;4(6):449–61. https://doi.org/10.2165/00002512-199404060-00002.
Tannenbaum C, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014a;174(6):890–8. https://doi.org/10.1001/jamainternmed.2014.949.
Tay WA, Griffen MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Enlg J Med. 1987;316:363–9.
Thillaindadesan J, Gnijidic D, Green S, Hilmer SN. Impact of deprescribing interventions in older hospitalized patients on prescribing and clinical outcomes: a systematic review of randomized trails. Drugs Aging. 2018;35(4):303–19. https://doi.org/10.1007/s40266-018-0536-4.
Thompson W, Hogel M, Li Y, Thavorn K, O'Donnell D, McCarthy L, Dolovich L, Black C, Farrell B. Effect of a proton pump inhibitor deprescribing guideline on drug usage and costs in long-term care. J Am Med Dir Assoc. 2016a;17(7):e1–673.
Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B. Deprescribing: future directions for research. Res Soc Adm Pharm. 2019;15(6):801–5. https://www.sciencedirect.com/science/article/pii/S1551741118307757)
Thompson W, et al. Nursing home Residents' thoughts on discussing Deprescribing of preventive medications. Drugs Aging. 2020a;37(3):187–92. https://doi.org/10.1007/s40266-020-00746-1.
Turner JP, et al. Economic evaluation of sedative Deprescribing in older adults by community pharmacists. J Gerontol A Biol Sci Med Sci. 2021;76(6):1061–7. https://doi.org/10.1093/gerona/glaa180.
Ulley J, Harrop D, Ali A, Alton S, Fowler DS. Deprescribing interventions and their impact on medication adherenece in community-dwelling older adults with polypharmacy: a systematic review. BMC Geriatr. 2019;19(1):15. https://doi.org/10.1186/s12877/s12877-019-1031-4.
Weir K, et al. Decision-making preferences and Deprescribing: perspectives of older adults and companions about their medicines. J Gerontol B Psychol Sci Soc Sci. 2018;73(7):e98–e107. https://doi.org/10.1093/geronb/gbx138.
Woodward MC. Deprescribing: achieving better Health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323–8.
Education Section References
(AFPC) Association of Faculties of Pharmacy of Canada Educational Outcomes for First Professional Degree Programs in Pharmacy in Canada 2017. https://www.afpc.info/system/files/public/AFPC-Educational%20Outcomes%202017_final%20Jun2017.pdf
(ASCP) American Society of Consultant Pharmacists Geriatric Pharmacy Curriculum Guide https://www.ascp.com/page/geriatriccurriculum
(CASN) Canadian Association of Schools of Nursing, Entry-to-Practice Gerontological Care Competencies for Baccalaureate Programs in Nursing 2017. https://www.casn.ca/wp-content/uploads/2016/09/FINAL_CASN-GERONTOLOGY-COMPETENCIES-FINAL.pdf
(CIHC) Canadian Interprofessional Health collaborative, a national Interprofessional competency Framework 2010. http://ipcontherun.ca/wp-content/uploads/2014/06/National-Framework.pdf
American Geriatrics Society. Beers criteria update expert panel. J Am Geriatr Soc. 2012;60(4):616–31.
American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767. Epub 2019 Jan 29
American Society for Consultant Pharmacists. https://www.ascp.com/
Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimizing potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014b;4:e006544. https://doi.org/10.1136/bmjopen-2014-006544.
Bardach SH, Rowles GD. Geriatric education in the health professions: are we making progress? Gerontologist. 2012;52(5):6-7-18.
Birkenholz RJ. Effective Adult Learning. 1999 ED436686.
Brundage DH, MacKeracher D. Adult Learning Principles and Their Application to Program Planning. 1980 ED181292.
Bruyère - Polypharmacy and Deprescribing (bruyere.org)
Canadian Deprescribing Network https://www.deprescribingnetwork.ca/reports
Canadian Pharmacists Association Products & Services - English (pharmacists.ca)
CanMEDS: Better standards, better physicians, better care. Royal College of Physicians and Surgeons of Canada. https://www.royalcollege.ca/rcsite/canmeds/canmeds-framework-e
CASN Canadian Association of Schools of nursing entry-to-practice public Health nursing competencies for undergraduate nursing education 2014. https://casn.ca/wp-content/uploads/2014/12/FINALpublichealthcompeENforweb.pdf
Centre for Effective Practice CEP | About
Charles L, Triscott JAC, Dobbs BM, et al. Geriatric Core competencies for family medicine curriculum and enhanced skills: care of elderly. Can Geriatrics J. 2014;17(2):53–62.
Cipolle RJ, Strand L, Morley P. Pharmaceutical Care. Practice. 1998b;1e
Cipolle RJM, Strand L, Morley PC. Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services, 3e. McGraw-Hill Education, LLC. Printed in the United States of America; 2012. ISBN 978-0-07-175638-9
Clyne B, Cooper JA, Hughes CM, Fahey T, Smith M. A process evaluation of a cluster randomized trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study). Trials. 2016a;17:386.
CNA Canadian Nurses Association RN Prescribing Framework 2015. https://cna-aiic.ca/en/professional-development/rn-prescribing-framework
Deprescribing website https://deprescribing.org/resources/publications/
Dutta AP, Daftary MN, Oke F, et al. Geriatric education in US schools of pharmacy: a snapshot. Consult Pharm. 2005;20(1):45–52. https://doi.org/10.4140/tcp.n.2005.45.
eCPS.
Farrell B, Thompson W, Black C, et al. Operationalizing the Canadian Interprofessional Health Collaborative (CIHC) Competency Framework for team management of polypharmacy in older persons: a modified Delphi validation. Can Pharm J. 2018b;151(6):395–407. https://doi.org/10.1177/2F1715163518804276.
Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (screening tool of older Person's prescriptions) and START (screening tool to alert doctors to right treatment) consensus validation. Int J Clin Pharmacol Ther. 2008b;46(2):72–83.
Gordon J. Updated survey of the geriatrics content of Canadian undergraduate and postgraduate medical curricula. Can Geriatrics J. 2011;14(2):34–9.
Hansen CR, O’Mahony D, Kearney PM, Sahm LJ, Cullinan S, Huibers CJA, et al. Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysis. Br J Clin Pharmacol. 2018b;84:2716–28.
Hirdes JP, Major J, Didic S, Quinn C, Mitchell L, Chen J, et al. A Canadian cohort study to evaluate the outcomes associated with a Multicenter initiative to reduce antipsychotic use in long-term care homes. JAMDA. 2020a;21:817–22.
Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:CD000259.
Kahl A, Blandford MA, Krueger K, Zwick DI. Geriatric education centres address medication issues affecting older adults. Public Health Rep. 1992;107(1):37–46.
Keijsers CJPW, van Doorn ABD, van Kalles A, de Wildt DJ, Bouwers JRBJ, van de Kamp H, et al. Structured Pharmaceutical analysis of the systematic tool to reduce inappropriate Prescribing is an effective method for Final-year medical students to improve polypharmacy skills: a randomized controlled trial. J Am Ger Soc. 2014;62(7):1353–9.
Kunstler BE, Lennox A, Bragge P. Changing prescribing behaviours with educational outreach: an overview of evidence and practice. BMC Med Educ. 2019;19(1):311. https://doi.org/10.1186/s12909-019-1735-3.
Mackey S, Bornsterin S. Deprescribing medications: barriers and enablers. NLCAHR May 2020. https://www.nlcahr.mun.ca/CHRSP/RER_Deprescribing_May_2020.pdf
Masud T, Blundell A, Gordon AL, Mulpeter K, Roller R, Singler K, et al. European undergraduate curriculum in geriatric medicine developed using an international modified Delphi technique. Age Ageing. 2014:1–8.
McIntosh J, et al. A case study of polypharmacy management in nine European countries: implications for change management and implementation. PLoS One. 2018a; https://doi.org/10.1371/journal.pone.0195232.
Miller GE. The assessment of clinical skills/competence/performance. Acad Med. 1990;65(9):S63–7.
Misiaszek BC, Borrie MJ, Grymonpre RE, Brymer CD, Crilly RG, Viana L. Canadian university faculties of pharmacy: undergraduate curriculum survey of geriatric. 2001.
NAPRA National Association of pharmacy regulatory authorities, professional competencies for Canadian pharmacists at entry to Practice 2014. https://napra.ca/sites/default/files/2017-08/Comp_for_Cdn_PHARMACISTS_at_EntrytoPractice_March2014_b.pdf
Picton C, Loughrey C, Webb A. The need for a prescribing competency framework to address the burden of complex polypharmacy among multiple long-term conditions. Clin Med. 2016;16(5):470–4. https://doi.org/10.7861/clinmedicine.16-5-470.
Poots AJ, Jubraj B, Barnett NL. Education around deprescribing: ‘spread and embed’ the story so far. Eur J Hosp Pharm Jan. 2017;24(10):7–9.
Poots AJ, Jubraj B, Ward E, et al. Education around medication review and deprescribing: a survey of medical and pharmacy students’ perspectives. Ther Adv Drug Saf. 2020;11:1–9. https://doi.org/10.1177/2042098620909610.
Pruskowski JA, Kane-Gill SL, Kavalieratos D, Wilson BK, Arnold RM, Handler SM. Feasibility of an academic detailing intervention to support deprescribing in the nursing home. JAMDA. July 27 2021.
Raman-Wilms L, Farrell B, Sadowski C, Austin Z. Deprescribing: an educational imperative. Res Soc Adm Pharm. 2019a;15(6):790–5. https://www.sciencedirect.com/science/article/pii/S1551741118307745)
RCPS Royal College of Physicians and Surgeons of Canada The Prescribing Safely Canada Physician Prescribing Competencies 2018. file:///Users/lraman/Downloads/psc-prescribing-competencies-e%20(1).pdf
Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014b;78(4):738–47.
Royal Pharmaceutical Society Competency Framework 2021. https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Prescribing%20Competency%20Framework/RPS%20Competency%20Framework.pdf?ver=AlHRKuior3ef_fNnaMd3iA%3d%3d
RPS Prescribing Competency Framework 2015. https://www.rpharms.com/resources/frameworks/prescribers-competency-framework
RxFiles.
Schmidt-Mende K, Hasselström J, Wettermark B, Andersen M, Bastholm-Rahmner P. General practitioners’and nurses’ views on medication reviews and potentially inappropriate medicines in elderly patients – a qualitative study of reports by educating pharmacists Scandinavian. J Primary Health Care. 2018;36(3):329–41. https://doi.org/10.1080/02813432.2018.1487458.
Scott I, Anderson K, Freeman C. 2017 review of structured guides for deprescribing. Eur J Hospital Pharm. 2017;24(1):51.
The Lown Institute, Eliminating Medication Overload: A National Action Plan January 2020. https://lowninstitute.org/reports/eliminating-medication-overload-a-national-action-plan/
Therapeutics Initiative Therapeutics Initiative | Better prescribing. Better health. – Better prescribing. Better health. (ubc.ca)
Woit C, Yuksel N, Charrois TL. Competence and confidence with prescribing in pharmacy and medicine: a scoping review. Int J Pharm Pract. 2020;28:312–25.
Zimmerman KM, Linsky AM, Donohoe KL, Hobgood SE, Sargent L, Salgado TM. An interprofessional workshop to enhance de-prescribing practices among health care providers. JCEHP. 2020;40(1):49–57.
Zolezzi M, Sadowski C, Al-Hasan N, et al. Geriatric education in schools of pharmacy: students’ and educators’ perspectives in Qatar and Canada. Curr Pharm Teach Learn. 2018;10:1184–96. https://doi.org/10.1016/j.cptl.2018.06.010.
Zou D, Tannenbaum C. Educational needs, practice patterns and quality indicators to improve geriatric pharmacy care. Can Pharm J. 2014;147(2):110–7.
Policy Section References
Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12:77. https://doi.org/10.1186/s13012-017-0605-9.
Canadian Deprescribing Network – Deprescribing by Policy https://static1.squarespace.com/static/5836f01fe6f2e1fa62c11f08/t/5ae9cc67f950b7f1080bbccd/1525271655720/Policy_infographic_13April2018_FINAL_web.pdf
Canadian Deprescribing Network – Deprescribing by Policy. https://static1.squarespace.com/static/5836f01fe6f2e1fa62c11f08/t/5ae9cc67f950b7f1080bbccd/1525271655720/Policy_infographic_13April2018_FINAL_web.pdf
Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37. http://www.implementationscience.com/content/7/1/37
Chen EYH, Kn W, Sluggett JK, Ilomäki J, Hilmer SN, Corlis M, et al. Process, impact and outcomes of medication review in Australian residential aged care facilities: a systematic review. Australas J Ageing. 2019;38(Suppl 2):9–25.
Dollman WB, Leblanc VT, Stevens L, O’Connor PJ, Roughead EE, Gilbert AL. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. Clin Pharm Ther. 2005;30:425–32.
Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W. Deprescribing guidelines: an international symposium on development, implementation, research and health professional education. Res Soc Adm Pharm. 2019a;15(6):780–9.
Fischer B, Jones W, Rehm J. Trends and changes in prescription opioid analgesic dispensing in Canada 2005–2012: an update with a focus on recent interventions. BMC Health Serv Res. 2014;14:90.
Fischer B, Jurgen R, Tyndall M. Effective Canadian policy to reduce harms from prescription opioids: learning from past failures. CMAJ. 2016;188:17–8.
Fisher J, Sanyal C, Frail D, Sketris I. The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. J Clin Pharm Ther. 2012;37:7–21.
Hansen CR, O’Mahony D, Kearney PM, Sahm LJ, Cullinan S, Huibers CJA, Thevelin S, Rutjes AWS, Knol W, Streit S, Byrne S. Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysis. Br J Clin Pharmacol. 2018c;84:2716–28.
High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly (United States). https://www.ncqa.org/hedis/measures/
Hirdes JP, Major J, Didic S, et al. A Canadian Cohort Study to Evaluate the Outcomes Associated with Multicenter Initiative to Reduce Antipsychotic Use in Long-Term Care Homes. J Post-Acute Long Term Care Medicine (JAMDA). 2020b;21(6):P817–22. https://doi.org/10.1016/j.jamda.2020.04.004.
Home Medicines Review (Australia). https://www.healthdirect.gov.au/home-medicines-review
Isenor E, Bai I, Cormier R, Jhelwig M, Reeve E, Whelan AM, Burgess S, Martin-Misener R, Kennie-Kaulbach N. Deprescribing interventions in primary health care mapped to the behaviour change wheel: a scoping review. RSAP. 2021b;17(7):1229–41.
Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. JAMA. 2018;320(18):1889–98. https://doi.org/10.1001/jama.2018.16131.
Medicare Part D prescription drug program, Medication Therapy Management service (United States). https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/MTM
Medication Management Reviews (Australia). https://www1.health.gov.au/internet/main/publishing.nsf/Content/medication_management_reviews.htm
Medicines management in care. homeshttps://www.nice.org.uk/guidance/qs85/chapter/quality-statement-5-medication-reviews
Medicines management in care homes (UK). https://www.nice.org.uk/guidance/qs85/chapter/quality-statement-5-medication-reviews
Medicines Use Review. https://www.psnz.org.nz/Category?Action=View&Category_id=449
Medicines Use Review (New Zealand). https://www.psnz.org.nz/Category?Action=View&Category_id=449
MedsCheck: MedsCheck - Health Care Professionals - MOHLTC (gov.on.ca)
Michie, et al. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implementation Sci. 2011;6(1):42. http://www.implementationscience.com/content/6/1/42
Ontario Pharmaceutical Opinion Program - Health Care Professionals - MOHLTC (gov.on.ca)
Rat C, Penhouet G, Gaultier A, Chaslerie A, Pivette J, Nguyen JM, et al. Did the new French pay-for-performance system modify benzodiazepine prescribing practices? BMC Health Serv Res. 2014;14:301.
Reid PP, Compton WD, Grossman JH, et al. Chapter 2, A Framework for a Systems Approach to Health Care Delivery. In: Building a Better Delivery System: A New Engineering/Health Care Partnership. Institute of Medicine. Washington, DC: The National Academies Press; 2005. https://doi.org/10.17226/11378.
Residential Medication Management Reviews https://www1.health.gov.au/internet/main/publishing.nsf/Content/medication_management_reviews.htm#:~:text=The%20Residential%20Medication%20Management%20Review,benefit%20from%20such%20a%20service
Residential Medication Management Reviews (Australia). https://www1.health.gov.au/internet/main/publishing.nsf/Content/medication_management_reviews.htm#:~:text=The%20Residential%20Medication%20Management%20Review,benefit%20from%20such%20a%20service
Sawan M, Reeve E, Turner J, Todd A, Steinman MA, Petrovic M, et al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020b;13(3):233–45.
Schaffer A, et al. Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: taking control of prescription drug use. JAMA Int Med. 2016;176(8):1223.
Shaw J, Murphy AL, Turner JP, Gardner DM, Silvius JL, Bouck Z, et al. Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults. Healthcare Policy. 2019;14(4):39–51.
SIMPATHY. http://simpathy.eu/vision-and-mission
Sketris IS, Kephart G, Frail DM, Skedgel C, Allen MJ. The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia seniors’ Pharmacare beneficiaries. Pharmacotherapy. 2004;24(6):784–91.
Steentoft A, Simonsen KW, Linnet K. The frequency of drugs among Danish drivers before and after the introduction of fixed concentration limits. Traffic Inj Prev. 2010;11(4):329–33. https://doi.org/10.1080/15389581003792783.
Stewart D, Mair A, Wilson M, Kardas P, Lewek P, Alonso A, McIntosh J. MacLure K and SIMPATHY consortium. Expert Opin Drug Saf. 2017;16(2):203–13. https://doi.org/10.1080/14740338.2017.1265503.
Structured Medication Reviews (UK). https://www.england.nhs.uk/publication/structured-medication-reviews-and-medicines-optimisation/
Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014b;174(6):890–8. https://doi.org/10.1001/jamainternmed.2014.949. PMID: 24733354
Tannenbaum C, Diaby V, Singh D, Perreault S, Luc M, Vasiliadis HM. Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective. Drugs Aging. 2015;32(4):305–14.
Wagner AK, Soumerai SB, Zhang F, Mah C, Simoni-Wastila L, Cosler L, et al. Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care. 2003;15(5):423–31.
Other References
Armstrong N, Swinglehurst D. Understanding medical overuse: the case of problematic polypharmacy and the potential of ethnography. Fam Pract. 2018;35(5):526–7.
Belcher VN, Fried TR, Agostini JV, Tinetti ME. Views of older adults on patient participation in medication-related decision making. J Gen Intern Med. 2006;21(4):298–303.
Blum, et al. Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM): cluster randomised controlled trial. BMJ. 2021;374 https://doi.org/10.1136/bmj.n1585.
Clyne B, Cooper JA, Hughes CM, Fahey T, Smith M. A process evaluation of a cluster randomized trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study). Trials. 2016b;17:386.
Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: mulitstage consultation process. BMJ. 2017a;359:j4891.
Elwyn G, Cochran N, Pignone M. Shared decision making – the importance of diagnosing preferences. JAMA Intern Med. 2017b;177(9):1239–40.
Fajardo MA, Weir KR, Bonner C, Gnjidic D, Jansen J. Availability and readability of patient education materials for deprescribing: an environmental scan. Br J Clin Pharmacol. 2019b;85 https://doi.org/10.1111/bcp.13912.
Farrell B, Richardson L, Raman-Wilms L, de Launay D, Alsabbagh MW, Conklin J. Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines. Res Soc Adm Pharm. 2018c;14(1):18–25.
Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W. Deprescribing guidelines: an international symposium on development, implementation, research and health professional education. Res Soc Adm Pharm. 2019b;15(6):780–9. https://www.sciencedirect.com/science/article/pii/S1551741118307447)
Farrell B, Grad R, Howell P, Quast T, Reeve E. Deprescribing guidelines: value of an interactive mobile application. PRiMER. 2020b;4:26.
Forsyth LP, Carman KL, Szydlowski V, Fayish L, Davidson L, Hickam DH, Hall C, Bhat G, Neu D, Steward L, Jalowsky M, Aronson N, Anyanwu CU. Patient engagement in research: early findings from the patient-centred outcomes research institute. Health Aff. 2019;38(3):359–67.
Good for you, Good for us, Good for everybody. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1019475/good-for-you-good-for-us-good-for-everybody.pdf
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990b;45(3):533–43.
Hoffmann T, Jansen J, Glasziou P. The importance and challenges of shared decision making in older people with multimorbidity. PLoS Med. 2018;15(3):e1002530.
ISMP 5 Questions to Ask - ISMP Canada (ismp-canada.org)
Lehman R. Sharing as the future of medicine. JAMA Intern Med. 2017;177(9):1237–8.
McCarthy D Reducing Inappropriate Medication Use by Implementing Deprescribing Guidelines. Cambridge, Massachusetts: Institute for Healthcare Improvement; 2017. (Available at ihi.org Reducing Inappropriate Medication Use by Implementing Deprescribing Guidelines | IHI - Institute for Healthcare Improvement
McIntosh J, Alonso A, MacLure K, Steward D, Kempen T, Mair A, et al. A case study of polypharmacy management in nine European countries: implications for change management and implementation. PLoS One. 2018b;13(4):e0195232.
McKellar GD, Hampson R, Tierney A, et al. Nonsteroidal antiinflammatory drug withdrawal in patients with stable rheumatoid arthritis. J Rheumatol. 2011b;38:2150–2.
Medication Safety in Polypharmacy. Geneva: World Health Organization; 2019 (WHO/UHC/SDS/2019.11). Licence: CC BY-NC-SA 3.0 IGO.
Moriarty F, Pottie K, Dolovich L, McCarthy L, Rojas-Fernandez C, Farrell B. Deprescribing recommendations: an essential consideration for clinical guideline developers. Res Soc Admin Pharm. 2019;15(6):806–10. https://www.sciencedirect.com/science/article/pii/S1551741118307770
O’Mahony, et al. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR∗ randomized controlled clinical trial. Age Ageing. 2020;49:605–14.
Ouellet GM, Ouellet JA, Tinetti ME. Principle of rational prescribing and deprescribing in older adults with multiple chronic conditions. Ther Adv Dru Saf. 2018;9(11):639–52.
Petersen AW, Shah AS, Simmons SF, Shotwell MS, Jacobsen JML, Myers AP, Mixon AS, Bell SP, Kripalani S, Schnelle JF, Vasilevskis EE. Shed-MEDS: pilot of a patient-centred deprescribing framework reduces medications in hospitalized older adults being transferred to inpatient postacute care. Ther Adv Dru Saf. 2018;9(9):523–33.
Raman-Wilms L, Farrell B, Sadowski C, Austin Z. Deprescribing: an educational imperative. Res Soc Adm Pharm. 2019b;15(6):790–5. https://www.sciencedirect.com/science/article/pii/S1551741118307745)
Rittel HWJ, Webber MM. Dilemmas in a general theory of planning. Policy Sci. 1973;4(2):155–69.
Swinglehurst D, Fudge N. Addressing the polypharmacy challenge in older people with multimorbidity: study protocol for an in-depth ethnographic case study in primary care. BMJ Open. 2019;9(8):e301601.
Talking about your medications workshop "Talking About Your Medications" Workshop Series - Deprescribing.org
Team Alice - Center for Successful Aging - University at Buffalo.
The Lown Institute. Eliminating medication overload: A national action plan, Working Group on Medication Overload. Brookline: The Lown Institute; 2020.
Thompson W, Hogel M, Li Y, Thavorn K, O'Donnell D, McCarthy L, Dolovich L, Black C, Farrell B. Effect of a proton pump inhibitor deprescribing guideline on drug usage and costs in long-term care. J Am Med Dir Assoc. 2016b;17(7):e1–673.
Thompson W, Videbaek J, Haastrup P, Nielsen JB, Pedersen LB, Jarbol DE. Exploring how GPs discuss statin deprescribing with older people: a qualitative study. BJGP Open. 2020b;4(1):bjgpopen20X101022.
Todd A, Jansen J, Colvin J, McLachlan AJ. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people. BMC Geriatr. 2018;18:295.
Turner JP, Tannenbaum C. Older adults’ awareness of deprescribing: a population-based survey. J Am Geriatr Soc. 2017;65:2691–6.
Turner JP, Currie J, Trimble J, Tannenbaum. Strategies to promote public engagement around deprescribing. Ther Adv Drug Saf. 2018;9(11):653–65.
Acknowledgments
We thank Dr. Justin Turner PhD, BPharm, MClinPharm for his expertise in reviewing the chapter.
Author information
Authors and Affiliations
Corresponding author
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Raman-Wilms, L., Farrell, B., Thompson, W. (2022). Deprescribing. In: Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Springer, Cham. https://doi.org/10.1007/978-3-030-50247-8_34-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-50247-8_34-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-50247-8
Online ISBN: 978-3-030-50247-8
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences
Publish with us
Chapter history
-
Latest
Deprescribing- Published:
- 09 May 2023
DOI: https://doi.org/10.1007/978-3-030-50247-8_34-2
-
Original
Deprescribing- Published:
- 18 November 2022
DOI: https://doi.org/10.1007/978-3-030-50247-8_34-1